These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

603 related articles for article (PubMed ID: 33615141)

  • 41. Superior possibilities and upcoming horizons for nanoscience in COVID-19: noteworthy approach for effective diagnostics and management of SARS-CoV-2 outbreak.
    Bhattacharjee B; Ikbal AMA; Farooqui A; Sahu RK; Ruhi S; Syed A; Miatmoko A; Khan D; Khan J
    Chem Zvesti; 2023 Apr; ():1-24. PubMed ID: 37362791
    [TBL] [Abstract][Full Text] [Related]  

  • 42. SARS-CoV-2: Mechanism of infection and emerging technologies for future prospects.
    Li S; Li S; Disoma C; Zheng R; Zhou M; Razzaq A; Liu P; Zhou Y; Dong Z; Du A; Peng J; Hu L; Huang J; Feng P; Jiang T; Xia Z
    Rev Med Virol; 2021 Mar; 31(2):e2168. PubMed ID: 35349206
    [TBL] [Abstract][Full Text] [Related]  

  • 43. An evidence-based systematic review on emerging therapeutic and preventive strategies to treat novel coronavirus (SARS-CoV-2) during an outbreak scenario.
    Gudadappanavar AM; Benni J
    J Basic Clin Physiol Pharmacol; 2020 Sep; 31(6):. PubMed ID: 32924964
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Emerging importance of nanotechnology-based approaches to control the COVID-19 pandemic; focus on nanomedicine iterance in diagnosis and treatment of COVID-19 patients.
    Hashemi B; Akram FA; Amirazad H; Dadashpour M; Sheervalilou M; Nasrabadi D; Ahmadi M; Sheervalilou R; Ameri Shah Reza M; Ghazi F; Roshangar L
    J Drug Deliv Sci Technol; 2022 Jan; 67():102967. PubMed ID: 34777586
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A review on the induction of host immunity by the current COVID-19 vaccines and a brief non-pharmaceutical intervention to mitigate the pandemic.
    Noor R
    Bull Natl Res Cent; 2022; 46(1):31. PubMed ID: 35194369
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Metabolomics-directed nanotechnology in viral diseases management: COVID-19 a case study.
    El-Derany MO; Hanna DMF; Youshia J; Elmowafy E; Farag MA; Azab SS
    Pharmacol Rep; 2023 Oct; 75(5):1045-1065. PubMed ID: 37587394
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Nanotechnology Platform for Advancing Vaccine Development against the COVID-19 Virus.
    Chowdhury N; Kundu A
    Diseases; 2023 Dec; 11(4):. PubMed ID: 38131983
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Nanotechnology Toolkit for Combating COVID-19 and Beyond.
    Muthiah G; Sarkar A; Roy S; Singh P; Kumar P; Bhardwaj K; Jaiswal A
    ChemNanoMat; 2022 Apr; 8(4):e202100505. PubMed ID: 35542043
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Nanomedicine: A Diagnostic and Therapeutic Approach to COVID-19.
    Sharma A; Kontodimas K; Bosmann M
    Front Med (Lausanne); 2021; 8():648005. PubMed ID: 34150793
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Advances of nanomaterials-based strategies for fighting against COVID-19.
    Zeng C; Hou X; Bohmer M; Dong Y
    View (Beijing); 2021 Aug; 2(4):20200180. PubMed ID: 34766161
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Can the application of graphene oxide contribute to the fight against COVID-19? Antiviral activity, diagnosis and prevention.
    Rhazouani A; Aziz K; Gamrani H; Gebrati L; Uddin MS; Faissal A
    Curr Res Pharmacol Drug Discov; 2021; 2():100062. PubMed ID: 34870157
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Magnetic-Nanosensor-Based Virus and Pathogen Detection Strategies before and during COVID-19.
    Wu K; Saha R; Su D; Krishna VD; Liu J; Cheeran MC; Wang JP
    ACS Appl Nano Mater; 2020 Oct; 3(10):9560-9580. PubMed ID: 37556271
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Potentialities of graphene and its allied derivatives to combat against SARS-CoV-2 infection.
    Hashmi A; Nayak V; Singh KR; Jain B; Baid M; Alexis F; Singh AK
    Mater Today Adv; 2022 Mar; 13():100208. PubMed ID: 35039802
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Nanotechnology in the COVID-19 era: Carbon-based nanomaterials as a promising solution.
    Papi M; De Spirito M; Palmieri V
    Carbon N Y; 2023 Jun; 210():118058. PubMed ID: 37151958
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Recent and advanced nano-technological strategies for COVID-19 vaccine development.
    Nwagwu CS; Ugwu CN; Ogbonna JDN; Onugwu AL; Agbo CP; Echezona AC; Ezeibe EN; Uzondu S; Kenechukwu FC; Akpa PA; Momoh MA; Nnamani PO; Tarirai C; Ofokansi KC; Attama AA
    Methods Microbiol; 2022; 50():151-188. PubMed ID: 38620863
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Nanotechnology Interventions in the Management of COVID-19: Prevention, Diagnosis and Virus-Like Particle Vaccines.
    Balkrishna A; Arya V; Rohela A; Kumar A; Verma R; Kumar D; Nepovimova E; Kuca K; Thakur N; Thakur N; Kumar P
    Vaccines (Basel); 2021 Oct; 9(10):. PubMed ID: 34696237
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A systemic review on liquid crystals, nanoformulations and its application for detection and treatment of SARS - CoV- 2 (COVID - 19).
    Rastogi A; Singh A; Naik K; Mishra A; Chaudhary S; Manohar R; Singh Parmar A
    J Mol Liq; 2022 Sep; 362():119795. PubMed ID: 35832289
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Applications of nanomaterials in COVID-19 pandemic.
    Xiao MF; Zeng C; Li SH; Yuan FL
    Rare Metals; 2022; 41(1):1-13. PubMed ID: 34539132
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Nanotechnology: A Potential Weapon to Fight against COVID-19.
    Tiwari AK; Mishra A; Pandey G; Gupta MK; Pandey PC
    Part Part Syst Charact; 2022 Jan; 39(1):2100159. PubMed ID: 35440846
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Outlook of various diagnostics and nanodiagnostic techniques for COVID-19.
    Preethi M; Roy L; Lahkar S; Borse V
    Biosens Bioelectron X; 2022 Dec; 12():100276. PubMed ID: 36345412
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.